$49.02
▼ -0.0% Today
as of Jul 22, 16:52 ET
Last 30 days
Recent Press Releases & News
PBH: Lowering target price to $45.00
Is the Options Market Predicting a Spike in Prestige Consumer Healthcare Stock?
Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date
Overview
52-week range
$43
$87
14% of range
Avg surprise (last 3)
-5.3%
Avg reaction (last 2)
+4.8%
100% positive
Latest IV / EM
44%
EM ±10.1% · $50 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 13, 2026 | Mar/2026 | $1.23 | $1.39 | -11.5% | -6.8% | +2.8% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $0.97 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.86 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $0.95 | $1.01 | -5.9% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $1.32 | $1.30 | +1.5% | — | +6.9% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $1.22 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $1.09 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.98 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $1.06 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $1.07 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $1.06 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | BMO | $0.89 | $0.95 | -6.3% |
Financials
Income statement (quarterly)
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $126M | $123M | $109M | — | $129M | $126M | $121M | — |
| Gross profit | $157M | $152M | $140M | — | $161M | $157M | $146M | — |
| Operating income | $82M | $80M | $72M | — | $92M | $84M | $72M | — |
| Net income | $47M | $42M | $47M | — | $61M | $54M | $49M | — |
| EPS (diluted) | $0.97 | $0.86 | $0.95 | — | $1.22 | $1.09 | $0.98 | — |
Balance sheet (quarterly)
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $62M | $119M | $140M | $98M | $51M | $52M | $34M | $46M |
| Inventory | $164M | $159M | $153M | $148M | $152M | $156M | $152M | $139M |
| Total current assets | $433M | $497M | $481M | $448M | $377M | $381M | $369M | $375M |
| Total assets | $3.49B | $3.44B | $3.43B | $3.40B | $3.33B | $3.32B | $3.31B | $3.32B |
| Long-term debt | — | — | — | — | $1.00B | $1.06B | $1.10B | $1.14B |
| Total liabilities | $1.67B | $1.62B | $1.58B | $1.57B | $1.54B | $1.59B | $1.63B | $1.66B |
| Total equity | $1.83B | $1.82B | $1.86B | $1.83B | $1.79B | $1.73B | $1.68B | $1.66B |